71 related articles for article (PubMed ID: 7716955)
1. [Comparison of the effectiveness of olicard 40 retard and cardonit 40 prolongatum preparations in treatment of stable coronary heart disease].
Kurpesa M; Krzemińska-Pakuła M; Kedzia E; Trzos E; Musiał W; Peruga Z
Wiad Lek; 1994 Aug; 47(15-16):587-90. PubMed ID: 7716955
[TBL] [Abstract][Full Text] [Related]
2. [The therapeutic and prophylactic use of Olicard-Retard under outpatient polyclinical conditions in stenocardia patients].
Mikhaĭlusova MP; Bart BIa; Kulikov SI; Smirnova OL; Anchipolovskaia NG; Mamtsev BN; Dergunova EN
Ter Arkh; 1997; 69(1):17-20. PubMed ID: 9163041
[TBL] [Abstract][Full Text] [Related]
3. Antianginal and anti-ischemic efficacy of nicorandil in comparison with isosorbide-5-mononitrate and isosorbide dinitrate: results from two multicenter, double-blind, randomized studies with stable coronary heart disease patients.
Döring G
J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S74-81. PubMed ID: 1282180
[TBL] [Abstract][Full Text] [Related]
4. [Isosorbide-5-mononitrate in silent ischemia].
Pichler M; Brandt D; Teubl H; Dorda W
Wien Klin Wochenschr; 1995; 107(13):390-5. PubMed ID: 7638969
[TBL] [Abstract][Full Text] [Related]
5. [Long-term tolerance and effect of isosorbide-5-mononitrate in comparison to isosorbide dinitrate (ISDN retard) in patients with coronary disease].
Smolarz A; Seeliger S; Glocke M
Med Welt; 1981 Apr; 32(14A):548-53. PubMed ID: 6787385
[No Abstract] [Full Text] [Related]
6. Comparative clinical trial of isosorbide 5-mononitrate and sustained-release isosorbide dinitrate in ischaemic heart disease.
Neuhaus R; Johnen R; Vydra L; Solbach C
Pharmatherapeutica; 1986; 4(8):486-95. PubMed ID: 3086899
[TBL] [Abstract][Full Text] [Related]
7. [Use of olicard retard in patients with stable angina of low effort in an outpatient setting].
Alekseeva NP; Runikhina NK; Lastovetskaia VI; Larin VG
Klin Med (Mosk); 2000; 78(8):72-4. PubMed ID: 11019532
[TBL] [Abstract][Full Text] [Related]
8. [Effect of 50 mg isosorbide-5-nitrate retard on the stress tolerance of patients with coronary heart disease].
Eggeling T; Jansen W; Osterspey A; Tauchert M; Hilger HH
Med Klin (Munich); 1986 Apr; 81(8):275-80. PubMed ID: 3785087
[No Abstract] [Full Text] [Related]
9. [Efficacy of mononitrate retard therapy in patients with advanced congestive heart failure].
Chmielewski M; Mamcarz A; Dłuzniewski M; Braksator W; Król J; Krysztofiak H; Kuch M; Beranek G
Pol Merkur Lekarski; 1997 Sep; 3(15):101-4. PubMed ID: 9461702
[TBL] [Abstract][Full Text] [Related]
10. [Antianginal effectiveness of regular isosorbide-5-mononitrate (monochinkwe retard) intake].
Golikov AP; Allenova IB; El'kina NS
Ter Arkh; 1999; 71(12):52-3. PubMed ID: 10647204
[No Abstract] [Full Text] [Related]
11. [Lack of tolerance after administration of delayed-action isosorbide-5-mononitrate for 3 days in patients with exercise-induced silent ischemia: control with placebo].
Scardi S; Pandullo C; Humar F; Spanghero M; Mazzone C
G Ital Cardiol; 1992 May; 22(5):549-57. PubMed ID: 1426792
[TBL] [Abstract][Full Text] [Related]
12. [The effect of IS-5-MN in coronary disease. Monocentric double-blind crossover comparison with ISDN retard and placebo].
Müller G; Schmidt-Voigt J
Med Welt; 1981 Apr; 32(14A):554-6. PubMed ID: 7242319
[No Abstract] [Full Text] [Related]
13. [Effectiveness of the delayed-action form of isosorbide 5-mononitrate in ischemic heart disease].
Hůla J; Trhlíková M
Vnitr Lek; 1991 Mar; 37(3):248-54. PubMed ID: 2031313
[TBL] [Abstract][Full Text] [Related]
14. Effects of isosorbide dinitrate on oxygen uptake kinetics in cardiac patients.
Koike A; Yajima T; Koyama Y; Shimizu N; Kano H; Kobayashi K; Taniguchi K; Marumo F; Hiroe M
Med Sci Sports Exerc; 1998 Feb; 30(2):190-4. PubMed ID: 9502344
[TBL] [Abstract][Full Text] [Related]
15. [Functional activity of platelet guanylate cyclase and cardiac hemodynamics in patients with chronic heart failure and relevant changes after treatment with isosorbide-5-mononitrate].
Ol'binskaia LI; Ushakova AV; Sizova ZhM
Ter Arkh; 1999; 71(9):77-9. PubMed ID: 10553632
[TBL] [Abstract][Full Text] [Related]
16. [Coronary artery disease observed in general hospitals: ETTIC study. Comparison between trimetazidine and mononitrate isosorbide for patients receiving betablockers].
Hanania G; Haïat R; Olive T; Maalouf B; Michel D; Martelet M; Godard S;
Ann Cardiol Angeiol (Paris); 2002 Nov; 51(5):268-74. PubMed ID: 12515103
[TBL] [Abstract][Full Text] [Related]
17. [4 different nitrate preparations with regard to the possible development of tolerance in long-term treatment].
Mertens HM; Ohlmeier H; Mannebach H; Kabelitz K; Gleichmann U
Herz; 1985 Jun; 10(3):172-81. PubMed ID: 3926614
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of dinitrate isosorbide retard forms in ischemic heart disease patients with stable effort angina].
Lupanov VP; Alekseeva IA; Vasil'eva NN; Komar OA; Romasiuk SS; Naumov VG
Ter Arkh; 2000; 72(9):33-6. PubMed ID: 11076413
[TBL] [Abstract][Full Text] [Related]
19. [Delayed-action isosorbide-5-mononitrate preparations--are there differences in the acute effect?].
Jansen W; Geppert R; Weidmann B; Tauchert M
Med Klin (Munich); 1987 Nov; 82(24):854-9. PubMed ID: 3431518
[No Abstract] [Full Text] [Related]
20. [Effects of nitrates and beta-blockers on platelet aggregation in patients with coronary heart disease].
Wlazłowski R; Kruszyński G; Goch JH
Pol Merkur Lekarski; 2000 Feb; 8(44):77-9. PubMed ID: 10808734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
